Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ROCHE DIAGNOSTICS A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   2.1% 2.2% 2.1% 8.8% 1.2% 2.0% 7.4% 7.3%   Credit score (0-100)   68 68 68 26 81 67 33 33   Credit rating   BBB BBB A BB A A BB BBB   Credit limit (mDKK)   0.0 0.0 0.0 -0.0 1.9 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   399 417 518 1,428 802 389 389 389   Gross profit   104 101 123 54.2 172 168 0.0 0.0   EBITDA   12.7 14.6 15.3 -100 51.3 11.8 0.0 0.0   EBIT   12.7 14.6 15.3 -100 51.3 11.8 0.0 0.0   Pre-tax profit (PTP)   10.0 11.2 11.7 -100.7 51.7 12.6 0.0 0.0   Net earnings   10.0 11.2 11.7 -80.2 54.5 -1.2 0.0 0.0   Pre-tax profit without non-rec. items   12.7 14.6 15.3 -101 51.7 12.6 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 3.4 8.1 4.7 0.0 0.0   Shareholders equity total   47.1 58.3 70.0 -10.2 44.3 46.7 43.4 43.4   Interest-bearing liabilities   0.0 0.0 0.0 273 18.6 2.0 0.0 0.0   Balance sheet total (assets)   160 162 256 509 177 158 43.4 43.4   Net Debt   0.0 0.0 0.0 273 18.6 2.0 -43.4 -43.4     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   399 417 518 1,428 802 389 389 389   Net sales growth   -7.5% 4.5% 24.2% 175.5% -43.8% -51.5% 0.0% 0.0%   Gross profit   104 101 123 54.2 172 168 0.0 0.0   Gross profit growth   -2.9% -3.1% 21.9% -55.8% 216.8% -2.3% -100.0% 0.0%   Employees   89 95 96 108 109 109 0 0   Employee growth %   4.7% 6.7% 1.1% 12.5% 0.9% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   160 162 256 509 177 158 43 43   Balance sheet change%   9.1% 1.4% 58.5% 98.6% -65.2% -11.1% -72.5% 0.0%   Added value   12.7 14.6 15.3 -100.4 51.3 11.8 0.0 0.0   Added value %   3.2% 3.5% 2.9% -7.0% 6.4% 3.0% 0.0% 0.0%   Investments   -1 0 0 3 5 -1 -7 0   Net sales trend   -2.0 1.0 2.0 3.0 -1.0 -2.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   3.2% 3.5% 2.9% -7.0% 6.4% 3.0% 0.0% 0.0%   EBIT %   3.2% 3.5% 2.9% -7.0% 6.4% 3.0% 0.0% 0.0%   EBIT to gross profit (%)   12.2% 14.5% 12.5% -185.3% 29.9% 7.0% 0.0% 0.0%   Net Earnings %   2.5% 2.7% 2.3% -5.6% 6.8% -0.3% 0.0% 0.0%   Profit before depreciation and extraordinary items %   2.5% 2.7% 2.3% -5.6% 6.8% -0.3% 0.0% 0.0%   Pre tax profit less extraordinaries %   3.2% 3.5% 2.9% -7.0% 6.4% 3.2% 0.0% 0.0%   ROA %   8.3% 9.1% 7.3% -25.9% 14.9% 7.6% 0.0% 0.0%   ROI %   11.6% 9.1% 7.3% -30.3% 20.7% 14.7% 0.0% 0.0%   ROE %   23.6% 21.2% 18.3% -22.5% 15.9% -2.7% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% -1.6% 21.2% 24.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 36.4% 16.6% 28.5% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 36.4% 16.6% 28.5% -11.2% -11.2%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% -271.5% 36.3% 16.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% -2,669.1% 42.0% 4.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.2% 0.2% 2.0% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 1.0 1.5 1.4 0.0 0.0   Current Ratio   0.0 0.0 0.0 1.3 1.7 1.9 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 80.9 27.3 53.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 35.4% 21.1% 38.7% 11.2% 11.2%   Net working capital   0.0 0.0 0.0 120.4 67.9 70.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 8.4% 8.5% 18.1% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   4 4 5 13 7 4 0 0   Added value / employee   0 0 0 -1 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 -1 0 0 0 0   EBIT / employee   0 0 0 -1 0 0 0 0   Net earnings / employee   0 0 0 -1 1 -0 0 0